Protein-ligand binding interactions of imidazolium salts with SARS CoV-2.

The disease called severe acute respiratory syndrome () is a lifestyle intimidating viral contamination affected by a positive, single stranded novel RNA virus () from the enveloped coronaviruse family. The COVID-2019 virus has affected many people, scattering promptly, and researchers are attempting to find out medicines for its effectual cure in all over the globe. Chloroquine () and its derivatives, an older drug used for the cure of malaria, is exposed to encompass a perceptible feasibility and commendable well-being in opposition to SARS CoV-2 associated pneumonia clinical trials conducted in China.